Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1/2 Study of ADI-SS PEG 20,000mw in Patients With Advanced Melanoma

NCT00520299 is registered in ClinicalTrials.gov with Ludwig Institute for Cancer Research as lead sponsor.

NCT NCT00520299
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00520299 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1/2 Study of ADI-SS PEG 20,000mw in Patients With Advanced Melanoma
Lead sponsor
Ludwig Institute for Cancer Research
Phase
Phase 1/2
Overall status
Completed
Start date
July 31, 2007
Completion date
March 31, 2010
Enrollment
31 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic melanoma, neoplasm, skin cancer